SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000166
Filing Date
2024-03-18
Accepted
2024-03-18 19:27:34
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5644
  Complete submission text file 0001610717-24-000166.txt   7068
Mailing Address C/O ANACOR PHARMACEUTICALS, INC. 1020 EAST MEADOW CIRCLE PALO ALTO CA 94303
Business Address
Chanda Sanjay (Reporting) CIK: 0001571820 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 24760631

Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)